Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicentric Trial Comparing Accelerated Partial Breast Irradiation (APBI) Versus Standard or Hypofractionated Whole Breast Irradiation in Low Risk of Local Recurrence of Breast Cancer

NCT01247233 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicentric Trial Comparing Accelerated Partial Breast Irradiation (APBI) Versus Standard or Hypofractionated Whole Breast Irradiation in Low Risk of Local Recurrence of Breast Cancer
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 27, 2010
Completion date
October 31, 2025
Enrollment
1,006 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lumpectomy